Director Juan Jose Chacon Quiros completed a series of transactions on March 23, 2026, selling a total of 34,025 common shares of Establishment Labs Holdings INC (NASDAQ: ESTA). The aggregate proceeds from the sales were roughly $2.05 million, with executed prices spanning from $60.232 to $63.01 per share.
Company filings further detail a transfer of 179,240 shares from Mr. Chacon Quiros' direct holdings into Sariel Group Ltd. The filings state that Mr. Chacon Quiros is a shareholder of Sariel Group Ltd. and possesses voting and dispositive power over the shares owned by that entity.
Following the March 23 transactions, Mr. Chacon Quiros' reported position consists of an indirect holding of 1,223,579 shares through Sariel Group Ltd., in addition to 45,193 shares held directly.
The insider activity occurred while Establishment Labs shares were trading at $55.98, after the stock had declined 8.3% over the previous week. An InvestingPro analysis cited in public notes indicates the stock appears overvalued relative to its Fair Value.
Investors reviewing the company's most recent financial update will note that Establishment Labs reported fourth-quarter 2025 results that exceeded analyst expectations. The company posted revenue of $64.6 million, compared with the anticipated $63.75 million. Reported earnings per share came in at -$0.09 versus a projected -$0.22, a variance characterized as a 59.09% positive surprise.
Market observers also recorded that Stephens raised its price target for Establishment Labs shares to $90 from $85 while keeping an Overweight rating. Stephens highlighted the company's robust revenue growth, noting a 45% increase year-over-year and U.S. revenue of $17.3 million. The firm also pointed to an expansion in gross margin of 200 basis points, reaching 70.5%, which was attributed to a favorable U.S. mix.
The combined disclosure of the insider sale, the intra-shareholder transfer to Sariel Group Ltd., and the recent quarterly beat provides a detailed snapshot of ownership movement and recent operational performance as reported by the company and analyst commentary.
Summary
On March 23, 2026, Director Juan Jose Chacon Quiros sold 34,025 Establishment Labs shares for about $2.05 million at prices between $60.232 and $63.01. He additionally transferred 179,240 shares to Sariel Group Ltd., an entity he controls. After these actions he holds 1,223,579 shares indirectly through Sariel Group Ltd. and 45,193 shares directly. These moves occurred as the stock traded at $55.98, down 8.3% over the prior week, and after the company reported a better-than-expected Q4 2025 with $64.6 million in revenue and EPS of -$0.09.
Key points
- Insider sale: 34,025 shares sold on March 23, 2026, for roughly $2.05 million at $60.232 to $63.01 per share.
- Ownership reorganization: 179,240 shares transferred to Sariel Group Ltd.; Mr. Chacon Quiros retains voting and dispositive power over Sariel Group Ltd.
- Recent performance: Q4 2025 revenue of $64.6 million and EPS of -$0.09 beat expectations; Stephens raised its price target to $90 from $85 and maintained an Overweight rating.
Risks and uncertainties
- Valuation concern - InvestingPro flags the stock as appearing overvalued relative to its Fair Value, a point that may influence investor sentiment.
- Market reaction - ESTA shares had declined 8.3% over the week leading up to and including the date of the insider sale, reflecting recent price volatility.
- Concentration and control - The transfer of a significant block of shares to Sariel Group Ltd., over which Mr. Chacon Quiros has voting and dispositive power, indicates continued concentrated ownership structure.